EAErin Angelini

Erin Angelini

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Erin Angelini has a total of 49 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Dynamics of ML-based Morphological Features Indicate a Shear Stress-dependent Bifurcation of hiPSC-derived Endothelial Cell States

    by Erin Angelini, Chantelle L. Leveille, Serge E. Parent, Rebecca J. Zaunbrecher, Tiffany Barszczewski, Julie C. Dixon, Fatwir S. Mohammed, Benjamin Morris, Jessica Yu, Joy Arakaki, et al.

    There is increasing interest in quantitatively combining phenotypic information and existing mathematical frameworks for cell state dynamics. We used hiPSC-derived endothelial cells as a controllable model system that adopts two distinct phenotypes at different magnitudes of shear stress. We trained a diffusion autoencoder model on timelapse imaging data to extract interpretable morphological features from brightfield. In this feature space, we found that observed phenotypic states correspond to stable fixed points of an inferred dynamical system. Cell migration coherence at these stable fixed points further distinguishes the states. Imaging cells across intermediate shear stresses revealed a regime of bistability, indicating that the shear-stress-dependent cell state transition occurs as a bifurcation. In N-terminally truncated VE-cadherin-expressing cells, we found that orientation and coherent migration were preserved, but morphology and migration speed were not. We demonstrate how machine learning and dynamical systems can be used in tandem to quantitatively characterize phenotypic cell states.

  • Open Access

    Dynamics of ML-based Morphological Features Indicate a Shear Stress-Dependent Bifurcation of hiPSC-Derived Endothelial Cell States

    by Erin Angelini, Chantelle L. Leveille, Serge E. Parent, Rebecca J. Zaunbrecher, Tiffany Barszczewski, Julie C. Dixon, Fatwir S. Mohammed, Benjamin Morris, Jessica S. Yu, Joy Arakaki, et al.

    Cell states are increasingly conceptualized as attractors of high-dimensional dynamical systems, yet quantitative approaches for integrating phenotypic information into this framework remain limited. Here, we take an image-based approach that combines unsupervised machine learning (ML) with timelapse imaging to extract and characterize the temporal dynamics of morphological features. Using a cell line with endogenously tagged VE-cadherin, we acquired brightfield and fluorescence timelapse images of human induced pluripotent stem cell-derived endothelial cell (hiPSC-EC) monolayers, which adopt distinct phenotypes at two different magnitudes of shear stress in terms of their morphology, behavior, and VE-cadherin organization. To quantify these phenotypic cell states without segmentation, we trained a diffusion autoencoder to predict VE-cadherin signal from brightfield images. We identified interpretable ML-based features representing cell orientation, elongation, and local density. Treating these variables as dimensions of a morphological state space, we estimated a data-driven vector field and found that the two observed phenotypic cell states correspond to stable fixed points of the inferred dynamical system. Mapping measured cell migration coherence onto this space further distinguished the states. Imaging cells across intermediate shear stresses revealed a regime of bistability in which both states coexist, indicating that the shear-stress-dependent transition between endothelial cell states occurs as a bifurcation of the inferred dynamical system. Finally, we applied this method to study an N-terminal truncation of VE-cadherin, finding that mutated cells preserve alignment and coherent migration, but exhibit altered morphology and increased migration speed. This work demonstrates the applicability of a dynamical systems approach to quantitatively characterize morphological aspects of cell state from interpretable ML-based features.

  • Statistical Analysis of Random Motion and Energetic Behavior of Counting: Gibbs’ Theory Revisited

    by Erin Angelini, Hong Qian

    Following a recently reformulated Gibbs' statistical chemical thermodynamic theory on discrete state space, we present a treatment on statistical measurements of random mechanical motions in continuous space. In particular, we show how the concept of temperature and an ideal gas/solution law arise from a statistical analysis of a collection of independent and identically distributed complex particles without relying on Newtonian mechanics, nor the very concept of mechanical energy. When sampling from an ergodic system, the data ad infinitum limit elucidates how the entropy function characterizes randomness among measurements with the emergence of a novel energetic representation for the statistics and an internal energy additivity. This generalization of Gibbs' theory is applicable to statistical measurements on single living cells and other complex biological organisms, one individual at a time.


  • Open Access

    A model for the intrinsic limit of cancer therapy: Duality of treatment-induced cell death and treatment-induced stemness

    by Erin Angelini, Yue Wang, Joseph Xu Zhou, Hong Qian, Sui Huang

    Intratumor cellular heterogeneity and non-genetic cell plasticity in tumors pose a recently recognized challenge to cancer treatment. Because of the dispersion of initial cell states within a clonal tumor cell population, a perturbation imparted by a cytocidal drug only kills a fraction of cells. Due to dynamic instability of cellular states the cells not killed are pushed by the treatment into a variety of functional states, including a “stem-like state” that confers resistance to treatment and regenerative capacity. This immanent stress-induced stemness competes against cell death in response to the same perturbation and may explain the near-inevitable recurrence after any treatment. This double-edged-sword mechanism of treatment complements the selection of preexisting resistant cells in explaining post-treatment progression. Unlike selection, the induction of a resistant state has not been systematically analyzed as an immanent cause of relapse. Here, we present a generic elementary model and analytical examination of this intrinsic limitation to therapy. We show how the relative proclivity towards cell death versus transition into a stem-like state, as a function of drug dose, establishes either a window of opportunity for containing tumors or the inevitability of progression following therapy. The model considers measurable cell behaviors independent of specific molecular pathways and provides a new theoretical framework for optimizing therapy dosing and scheduling as cancer treatment paradigms move from “maximal tolerated dose,” which may promote therapy induced-stemness, to repeated “minimally effective doses” (as in adaptive therapies), which contain the tumor and avoid therapy-induced progression.


  • Open Access

    A model for the intrinsic limit of cancer therapy: duality of treatment-induced cell death and treatment-induced stemness

    by Erin Angelini, Yue Wang, Joseph X. Zhou, Hong Qian, Sui Huang

    A bstract: Intratumor cellular heterogeneity and non-genetic cell plasticity in tumors pose a recently recognized challenge to cancer treatment. Because of the dispersion of initial cell states within a clonal tumor cell population, a perturbation imparted by a cytocidal drug only kills a fraction of cells. Due to dynamic instability of cellular states the cells not killed are pushed by the treatment into a variety of functional states, including a “stem-like state” that confers resistance to treatment and regenerative capacity. This immanent stress-induced stemness competes against cell death in response to the same perturbation and may explain the near-inevitable recurrence after any treatment. This double-edged-sword mechanism of treatment complements the selection of preexisting resistant cells in explaining post-treatment progression. Unlike selection, the induction of a resistant state has not been systematically analyzed as an immanent cause of relapse. Here, we present a generic elementary model and analytical examination of this intrinsic limitation to therapy. We show how the relative proclivity towards cell death versus transition into a stem-like state, as a function of drug dose, establishes either a window of opportunity for containing tumors or the inevitability of progression following therapy. The model considers measurable cell behaviors independent of specific molecular pathways and provides a new theoretical framework for optimizing therapy dosing and scheduling as cancer treatment paradigms move from “maximal tolerated dose,” which may promote therapy induced-stemness, to repeated “minimally effective doses” (as in adaptive therapies), which contain the tumor and avoid therapy-induced progression.